|
|
|
14 Sep 2006 |
Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
|
|
14 Sep 2006 |
Transition Therapeutics Inc. and JDRF Announce Partnership to Develop Diabetes Regenerative Product GLP1-I.N.T.(TM)
|
|
13 Sep 2006 |
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
|
|
13 Sep 2006 |
Gloucester Pharmaceuticals Initiates Phase I/II Clinical Study in Pancreatic and Other Advanced Solid Tumors
|
|
13 Sep 2006 |
ConjuChem Discloses Final Results Of PC-DAC:Exendin-4 Phase I/II Trial For Type 2 Diabetes - Update
|
|
12 Sep 2006 |
Stem Cell Therapeutics Corp. Announces Enrolment of First Patient in Phase IIa Study
|
|
12 Sep 2006 |
BioMarin Provides Update on Phenylase Product Development
|
|
12 Sep 2006 |
Investigators Report New Renal, Mortality and Safety Data from NAPA Trial of NATRECOR(R) (nesiritide)
|
|
08 Sep 2006 |
Amgen Launches Aranesp(R) (Darbepoetin Alfa) Prefilled SureClick(TM) Autoinjector for Treatment of Anemia Associated with Chemotherapy and Chronic Kidney Disease
|
|
08 Sep 2006 |
SYMLIN Improved Diabetes Control in Patients With Type 2 Diabetes on Established Regimens of Basal Insulin
|
|
08 Sep 2006 |
XOMA Announces Development Plan for XOMA 629 in Acne; Reformulation Efforts Successful; Clinical Trials Planned
|
|
07 Sep 2006 |
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
|
|
06 Sep 2006 |
Nuvelo Phase 2 Trial Results Show rNAPc2 Has the Potential to Reduce Ischemia in Patients With ACS
|
|
06 Sep 2006 |
Maxygen Initiates Phase I Clinical Trial for Maxy-G34
|
|
06 Sep 2006 |
ZymoGenetics Reports Positive Results From Pivotal Phase 3 Clinical Trial of rhThrombin
|
|
06 Sep 2006 |
Emisphere's eligen(R) Technology Demonstrates Delivery of Active Recombinant Human Growth Hormone
|
|
06 Sep 2006 |
Salix Pharmaceuticals and Debiopharm Sign SANVAR(R) License Agreement
|
|
06 Sep 2006 |
Nuvelo Announces Completion of Patient Enrollment in NAPA-2, First Phase 3 Trial of Alfimeprase in Acute Peripheral Arterial Occlusion
|
|
06 Sep 2006 |
Nuvelo Announces Completion of Patient Enrollment in SONOMA-2, First Phase 3 Trial of Alfimeprase in Central Venous Catheter Occlusion
|
|
06 Sep 2006 |
Aida Pharmaceuticals Releases Update on Qiaer Biotechnology Acquisition and Rh-Apo2L
|
|
06 Sep 2006 |
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
|
|
04 Sep 2006 |
US Army to Conduct Phase 2 Trial of Glypromate(R) to Reduce Brain Injury From Cardiac Arrest
|
|
01 Sep 2006 |
Dyax Announces Update Regarding Regulatory Pathway for DX-88 (ecallantide) in Hereditary Angioedema; FDA confirms 30 mg subcutaneous dose as appropriate dose; Dyax plans small confirmatory study
|
|
31 Aug 2006 |
PDL BioPharma Announces Roche Discontinuation of Co-Development of Daclizumab in Asthma
|
|
30 Aug 2006 |
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
|
|
30 Aug 2006 |
OrthoLogic Announces Results of Preliminary Interim Analysis of Phase 2b Clinical Trial of Chrysalin(R) (TP508) in Fracture Repair
|
|
29 Aug 2006 |
Allon begins dosing for AL-108 Phase Ib clinical trial
|
|
29 Aug 2006 |
BioAxone Therapeutic announces patients completed the 6 week follow-up in the Phase I/IIa Trial of Cethrin(R) for the treatment of acute spinal cord injury
|
|
24 Aug 2006 |
Phosphagenics successfully delivers insulin across the skin in humans
|
|
24 Aug 2006 |
Questcor Files sNDA for Treatment of Infantile Spasms with H.P. Acthar(R) Gel; FDA Accepts Application for Review
|
|
23 Aug 2006 |
Fresenius Kabi and Sandoz to cooperate in the development of an HESylated biopharmaceutical drug
|
|
23 Aug 2006 |
Diamyd(TM) Diabetes Drug Shows Efficacy In A Phase II Type 1-Diabetes Trial
|
|
22 Aug 2006 |
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study
|
|
22 Aug 2006 |
Altus Pharmaceuticals Secures Phase III Manufacturer, Althea Technologies, for ALTU-238
|
|
18 Aug 2006 |
Landmark BENEFIT trial results of Betaferon (R) in early MS published in Neurology
|
|
18 Aug 2006 |
Pharming’s Marketing Authorization Application For Rhucin(R) (rhC1INH) Accepted For Review By EMEA
|
|
18 Aug 2006 |
Serono Announces Results From Pivotal Phase III Clinical Trial Of Its Proprietary Recombinant Human Growth Hormone In The Treatment Of HARS At The XVI International Aids Conference
|
|
18 Aug 2006 |
Advanced Refractive Achieves Early Milestone
|
|
16 Aug 2006 |
XOMA Unveils Strategy, Provides Update on NEUPREX(R); European Effort Advances Toward Orphan Drug Designation and Approval Under Exceptional Circumstances; US Trials Progress
|
|
15 Aug 2006 |
Nastech Initiates Dose Ranging Study of PYY(3-36) Nasal Spray for Obesity
|
|
12 Aug 2006 |
Amarillo Biosciences IND Application Passes FDA Review
|
|
11 Aug 2006 |
Dutch Biopharmaceutical Company AM-Pharma Strengthens Intellectual Property Position for Lactoferrin Derived Antimicrobial Peptide hLF1-11
|
|
11 Aug 2006 |
Vyteris Announces Positive Results in Two Phase I Clinical Trials for Treatment of Infertility; Data Indicate Actyve(TM) Transdermal Drug Delivery Achieves Therapeutic Levels Of A Peptide Used For Treatment Of Infertility In Humans
|
|
11 Aug 2006 |
Advanced Viral Research (ADVR) Announces Results of Phase I Study on Type 2 Diabetes
|
|
11 Aug 2006 |
cGMP Manufacturing Contract Signed by Proteon Therapeutics, Inc., and QSV Biologics, Ltd., for PRT-201 Clinical Phase I Material Supply
|
|
10 Aug 2006 |
Protox advances Phase I prostate cancer study and planned BPH clinical trial
|
|
09 Aug 2006 |
LAB International Completes Patient Enrollment In LAB-CGRP Phase IIa Trial
|
|
09 Aug 2006 |
Potentia Pharmaceuticals Licenses Complement Inhibitor from the University of Pennsylvania
|
|
08 Aug 2006 |
ConjuChem provides findings of DAC(TM):GRF HIV Lipodystrophy trial investigation
|
|
08 Aug 2006 |
Halozyme Therapeutics Initiates First Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Molecule Protein Therapeutic
|
| |
|
Results 1051 - 1100 of 1426 |
